Melanoma Institute Australia launches free e-learning education portal
20 June 2018
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment to ensure best practice and equity of care for melanoma patients around the country.
The new online education portal is designed for healthcare professionals including specialists, dermatologists, GPs and nurses. It provides accredited videos and comprehensive training modules relating to the rapidly changing melanoma diagnostic and treatment landscape.
Melanoma Institute Australia Conjoint Medical Director, Professor Georgina Long, said the e-learning portal would ultimately improve melanoma patient care and outcomes within Australia and internationally.
“Our new education portal will be practice changing for healthcare professionals, particularly those who do not normally specialise in diagnosing and treating melanoma,” Professor Long said. “It gives them access to training modules covering best practice in diagnosing and managing melanoma, as well as translating world-leading research into clinical knowledge to ultimately improve patient outcomes.”
MIA Conjoint Medical Director, Professor Richard Scolyer, added, “We’re excited to bring together the collective expertise from MIA, which is the world’s largest research and treatment institute with a single focus on melanoma. The portal will ensure healthcare professionals have free 24/7 access to the latest advances in melanoma clinical practice and research, regardless of where they are located. This will benefit melanoma patients all over the world, and ultimately, save lives.” he said.
New content will be added to the site regularly and registered healthcare professionals can earn accreditation points. Healthcare professionals are invited to access the free site by registering at melanomaeducation.org.au
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.
MIA's 'Stop the Spread' campaign has been shortlisted in the 2016 Cannes Lions International Festival of Creativity.
MIA's doctors are converging on Chicago this week along with 40,000 delegates from around the globe at the biggest oncology conference in the world.
We are pleased to announce a recent expansion to the dermatology services at Melanoma Institute Australia.
This International Clinical Trials Day we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future.
MIA has launched its first eBook Melanoma Essentials – A Concise Guide, a resource for GPs and other medical, nursing and allied professionals to help them effectively diagnose and manage cases.
Dr Scot Ebbinghaus chats to us about an exciting clinical trial at MIA and where melanoma treatment is headed in the future.
A new melanoma treatment has been listed on the PBS today, giving another option for advanced melanoma patients.
MIA's Pathology Fellow Dr Louise Jackett tells us why she's joined our fellowship program to learn from the best.
MIA doctors and patient have featured in the final episode of ABC’s ground-breaking series Keeping Australia Alive.
Specialist dermatologists at MIA are researching moles during pregnancy and we are looking for study recruits.
New research is re-writing the textbooks on what we know about melanoma by highlighting the effectiveness of radiotherapy as a treatment, reversing a long-held belief that melanoma was resistant to radiotherapy.
However, Australia's burden of melanoma will stay very high over the next 15 years unless we do more. MIA's Professor Graham Mann explains.
Thank you to everyone involved in making Melanoma March 2016 a huge success